First outbreak of Clostridium difficile infections in Serbia: An experience of the department for orthopedic surgery

Abstract

Objectives: Increased C. difficile infection rates were observed during the last decade, as well as the onset of complicated forms of the disease. The primary objective of this study was to report the first outbreak of C. difficile in a Serbian hospital, aiming to determine clinical and environmental factors associated with the outbreak. The secondary objective was to describe outbreak control measures taken.

Design: The retrospective cohort study conducted from 18 April to 22 May 2013 in Serbian healthcare. Ninety-five patients hospitalized at the Department for orthopedic surgery during the CDI outbreak.

Results: Prophylactic antibiotic therapy was identified among 93.3% patients with and 87.9% without C. difficile infection. The multivariate logistic regression analysis has shown that the independent risk factors for C. difficile infection incidence are the age beyond 70 (OR = 4.5; 95%CI = 1.1-18.2; p =.031) and the length of antibiotic therapy (OR = 1.5; 95%CI = 1.1-2.1; p =.017).

Conclusion: The length of antibiotic prophylaxis is linked with the incidence. Orthopedic departments have a risk of C. difficile infection. Infection control measure, antimicrobial stewardship programs and compliance to guidelines for the prescribing of antibiotics play important role in the prevention of C. difficile infection burden.

Keywords

Clostridium difficile infection / Epidemic / Risk factors / Disease outbreak / Prevention

References

[1] Jullian-Desayes I, Landelle C, Mallaret MR, et al. Clostridium difficile contamination of health care workers’ hands and its potential contribution to the spread of infection: Review of the literature. Am J Infect Control. 2017; 45: 51-8. PMid:28065332. https://doi.org/10.1016/j.ajic.2016.08.017

[2] Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis. 2008 Jun; 14: 929-31. https://doi.org/10.3201/eid1406.071447

[3] Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005 Dec; 353: 2442-9. https://doi.org/10.1056/NEJMoa051639

[4] McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med. 2005 Dec; 353: 2433-41. https://doi.org/10.1056/NEJMoa051590

[5] Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005 Sep; 366: 1079-84. https://doi.org/10.1016/S0140-6736(05)67420-X

[6] Davies KA, Ashwin H, Longshaw CM, et al, EUCLID study group. Diversity of Clostridium difficile PCR ribotypes in Europe: results from the European, multicentre, prospective, biannual, point prevalence study of Clostridium difficile infection in hospitalised patients with diarrhoea (EUCLID), 2012 and 2013. Eurosurveillance. 2016; 21: pii=30294. https://doi.org/10.2807/1560-7917.ES.2016.21.29.30294

[7] ECDC. Clostridium difficile infections. Annual Epidemiological Report for 2016. European Centre for Disease prevention and Control, Stocholm, 2018. Available from: https://ecdc.europa.eu/sites/portal/files/documents/AER_for_2016-C-difficile.pdf

[8] Rupnik M, TambicAndrasevic A, Trajkovska Dokic E, et al. Distribution of Clostridiumdifficile PCR ribotypes and highproportion of 027 and 176 in some hospitals in four South Eastern European countries. Anaerobe. 2016 Dec; 42: 142-44. PMid:27751937. https://doi.org/10.1016/j.anaerobe.2016.10.005

[9] Institute of Public Health of Serbia.Annual Report of Communicable Diseases, 2011. Institute of Public Health of Serbia, Belgrade; 2012 (in Serbian).

[10] Institute of Public Health of Serbia.Annual Report of Communicable Diseases, 2013. Belgrade: Institute of Public Health of Serbia, 2014 (in Serbian).

[11] ECDC.Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals Protocol version 4.3. Stocholm: European Centre for infection prevention and Control; 2012.

[12] Ministry of Healthof Republic of Serbia. Rulebook on Prevention, Early Detection and Control of Health care associate infections. Official Gazette of Republic of Serbia, 2015 (in Serbian).

[13] Suljagic V, Djor¯devi´c D, Lazic S, et al. Epidemiological Characteristics of Nosocomial Diarrhea Caused by Clostridium Difficile in a Tertiary Level Hospital in Serbia. Srp Arh Celok Lek. 2013 Jul-Aug; 141: 482-89. PMid:24073554. https://doi.org/10.2298/SARH1308482S

[14] Dubberke ER, Reske KA, Yan Y, et al. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007 Dec; 45: 1543-9. https://doi.org/10.1086/523582

[15] Pépin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ. 2005 Oct; 173: 1037-42. https://doi.org/10.1503/cmaj.050978

[16] Lango D. Clostridium difficile infections. New Engl J Med. 2015 Apr; 372: 1539-48.

[17] Al-Obaydi W, Smith CD, Foguet P. Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoealinfections. J Orthop Surg. (Hong Kong). 2010 Dec; 18: 320-3. https://doi.org/10.1177/230949901001800312

[18] Qu HQ, Jiang ZD. Clostridium difficile infections in diabetes. Diabetes Res Clin Pract. 2014 Sep; 105: 285-94. https://doi.org/10.1016/j.diabres.2014.06.002

[19] Ministry of Health of Republic of Serbia. Instruction for Prevention and Control of Hospital Infections caused by C. difficile. Official Gazette of Republic of Serbia, 2013 (in Serbian).

[20] Cohen S, Gerding D, Johnson S, et al. Society for Healthcare Epidemiology of America; Infectious Diseases Society of America: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp. Epidemiol. 2010 May; 31: 431-55.

[21] Surawicz C, Brandt L, Binion D, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr; 108: 478-498. https://doi.org/10.1038/ajg.2013.4

[22] Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database System Rev. 2013; 4: Cd003543. https://doi.org/10.1002/14651858.CD003543.pub3

[23] Feazel LM, Malhotra A, Perencevich EN, et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014 Jul; 69: 1748-54. PMid:24633207. https://doi.org/10.1093/jac/dku046